Please login to the form below

Not currently logged in
Email:
Password:

Ferring promotes Lars Peter Brunse to chief production officer

He also joins the Swiss pharma firm's executive board

Saint-Prex, Switzerland-based Ferring Pharmaceuticals has appointed Lars Peter Brunse as its vice president and chief production officer, roles that will also see him join the Ferring executive board.

Brunse first joined Ferring as associate director, technical operations in 2000 and was promoted to senior vice president, technical operations and logistics where he led the expansion of the firm’s manufacturing capability with the development of an additional nine state-of-the-art production sites, and extended the company’s product supply network.

Michel Pettigrew, president of the executive board and chief operating office of Ferring Pharmaceuticals, said: “Lars Peter has been instrumental in expanding Ferring’s production capacity, most recently through the successful completion of new sites in the US and India.

“His team-focussed leadership style has been extremely effective in building a strong product supply organisation, and his experience makes him uniquely qualified for this new role.”

Prior to joining Ferring, Brunse served Novo Nordisk in manufacturing, operational excellence and quality assurance management.

6th July 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Thrive Agency

We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...

Latest intelligence

Lifting the fog to help Clinical Labs navigate IVDR 2022
In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests. BD wanted to let their...
Empowering adolescents to manage emotional and mental health issues
1 in 10 UK children suffer with a mental health issue and alarmingly as many as 70% of these don’t receive the proper support they need. That’s why The Anna...
Reframing rare to increase earlier diagnosis of Gaucher Disease
Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its...